Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy
2 other identifiers
interventional
64
1 country
1
Brief Summary
The purpose of this study is to compare the safety and superiority of Roux-Y versus Billroth II gastrojejunostomy reconstruction on delayed gastric emptying after pancreatoduodenectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 7, 2013
CompletedFirst Posted
Study publicly available on registry
November 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedAugust 29, 2016
August 1, 2016
2.8 years
November 7, 2013
August 26, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of delayed gastric emptying (DGE)
30 day after surgery
Study Arms (2)
Roux-en-Y
EXPERIMENTALRoux-en-Y for the gastrojejunostomy reconstruction
Billroth II
ACTIVE COMPARATORBillroth II for the gastrojejunostomy reconstruction
Interventions
Eligibility Criteria
You may qualify if:
- Consecutive series of patients undergoing pancreaticoduodenectomy (PD).
- Given informed consent.
You may not qualify if:
- Inability to perform pancreatogastrostomy.
- Resection of other organs, except the superior mesenteric-portal vein.
- Previous gastric surgery.
- Preoperative gastric or duodenal obstruction.
- Previous complex abdominal surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Complejo Hospitalario de Navarra
Pamplona, Navarre, 31008, Spain
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francisco Javier Herrera, MD
Complejo Hospitalario de Navarra
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2013
First Posted
November 14, 2013
Study Start
November 1, 2013
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
August 29, 2016
Record last verified: 2016-08